1. Home
  2. PDYN vs SAVA Comparison

PDYN vs SAVA Comparison

Compare PDYN & SAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Palladyne AI Corp.

PDYN

Palladyne AI Corp.

HOLD

Current Price

$4.42

Market Cap

254.4M

Sector

Industrials

ML Signal

HOLD

Logo Cassava Sciences Inc.

SAVA

Cassava Sciences Inc.

HOLD

Current Price

$2.18

Market Cap

156.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDYN
SAVA
Founded
1983
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Wholesale Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
254.4M
156.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PDYN
SAVA
Price
$4.42
$2.18
Analyst Decision
Hold
Buy
Analyst Count
1
2
Target Price
$8.00
$5.00
AVG Volume (30 Days)
1.5M
992.9K
Earning Date
11-12-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,346,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$250.22
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.02
$1.15
52 Week High
$14.95
$4.98

Technical Indicators

Market Signals
Indicator
PDYN
SAVA
Relative Strength Index (RSI) 31.92 30.64
Support Level $4.14 $2.77
Resistance Level $4.64 $3.32
Average True Range (ATR) 0.34 0.21
MACD -0.03 -0.06
Stochastic Oscillator 13.77 7.00

Price Performance

Historical Comparison
PDYN
SAVA

About PDYN Palladyne AI Corp.

Palladyne AI Corp is a software company focused on autonomy for robotic systems and solutions. Its artificial intelligence and machine learning software seeks to revolutionize the capabilities of robots, enabling them to observe, learn, reason, and act in structured and unstructured environments. AI and ML software platform of the company empowers robots to perceive variations or changes in the real-world environment, enabling them to autonomously maneuver and manipulate objects accurately in response. Palladyne AI software has wide application, including in industries such as automotive, aviation, construction, defense, general manufacturing, infrastructure inspection, logistics and warehousing.

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

Share on Social Networks: